Paragon Capital Management LLC Novartis Ag Transaction History

Paragon Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 03, 2020	SELL	$80.93 - $91.1 $5,746 - $6,468	-71 Closed	0 $0
Q1 2020 May 01, 2020	BUY	$70.67 - $99.01 $5,017 - $7,029	71 New	71 $6,000
Q3 2019 Oct 31, 2019	SELL	$85.54 - $94.26 $22,154 - $24,413	-259 Closed	0 $0
Q2 2019 Aug 06, 2019	BUY	$75.4 - $92.8 $15,683 - $19,302	208 Added 407.84%	259 $24,000
Q1 2019 Apr 15, 2019	BUY	$75.32 - $86.15 $3,841 - $4,393	51 New	51 $5,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Paragon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Paragon Capital Management LLC with notifications on news.